Hans Küpper

Dr. Küpper has more than 30 years of experience in biotechnology, including activities ranging from research to R&D management to technology assessment and acquisition.

He joined Global Life Science Ventures in 1999 as a managing director of GLSI’s advisory company, based in Munich, Germany. His career in biotech began in 1980 at Biogen, one of the first biotech companies, at its European headquarters in Geneva. In 1985, he joined Behringwerke AG to establish and head their molecular biology department. Later, Dr. Küpper became head of R&D and member of the board of the company’s immunology/oncology business unit. His most recent non-executive board seats have included Pieris AG (Freising, Germany, chairman); Santaris A/S (Copenhagen, Denmark); Action Pharma A/S (Copenhagen, Denmark); IMI, Intelligent Medical Implants AG (Zug, Switzerland); and Intercell AG (Vienna, Austria).

Dr. Küpper received his Ph.D. from the University of Heidelberg in 1974 and spent two years as a post-doctoral fellow at MIT in Boston with Nobel Laureate Har Gobind Khorana.